← All claims

Sweeteners · Metabolic & Cardiometabolic

monk fruit does not raise blood glucose

Strong support Sweeteners

Part of: • monk fruit

RefutedContestedStrong support
consensus score 0.96

Evidence ladder

How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."

Top evidence so far: All trials, pooled (Meta-analysis)

MechanismIn-vitroAnimalObservationalRCTMeta-analysis

How the studies fall

7 support 0 contradict 0 tested null 1 mixed · 8 sources, 7 independent groups

What the evidence shows

Monk-fruit (mogroside) sweetener is non-caloric and glycemically neutral: acute RCTs show lower glucose and insulin responses than sugar, and a PRISMA systematic review of RCTs supports its metabolic neutrality. The human evidence base is still thin (few trials), but consistently points to no meaningful blood-glucose rise. measured_by:: [[blood glucose]]

The evidence (8)

SourceGradeStanceQualityFinding
Msomi et al.
2021 · J Food Drug Anal
observational supports low Review: monk-fruit/mogroside non-glycemic, suitable for glucose control.
Zhou et al.
2009 · Acta Pharm Sin
animal mixed low In-vitro/animal: mogroside V stimulates insulin secretion — a mechanism that would aid, not raise, glycemia (non-human).
Teysseire et al.
2024 · Nutrients
observational supports moderate Narrative review: monk fruit no adverse glycemic effect vs sugar.
Wolnerhanssen et al.
2020 · Crit Rev Food Sci Nutr
observational supports moderate Metabolic review: mogroside sweeteners glycemically neutral.
Tey et al.
2017 · Int J Obes
RCT supports moderate RCT: monk-fruit-sweetened beverage produced lower postprandial glucose and insulin than sucrose.
Kaim et al.
2025 · Nutrients
meta-analysis supports moderate PRISMA systematic review of RCTs of monk fruit extract: supports metabolic neutrality / no adverse glycemic effect.
Dragomir et al.
2025 · Foods
observational supports low Holistic sweetener review: monk fruit non-caloric, negligible glycemic index.
Almiron-Roig et al.
2023 · Appetite
RCT supports moderate SWEET beverages RCT: mogroside-V/stevia blend reduced insulin iAUC vs sucrose.

Disagree, or know a study we missed?

We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.

📚 Suggest a study ⚑ Flag / request reclassification

Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).

Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.